253 related articles for article (PubMed ID: 8769214)
1. Maintenance immunosuppression using cyclosporine monotherapy in adult orthotopic liver transplant recipients.
Tchervenkov JI; Tector AJ; Cantarovich M; Tahta SA; Asfar A; Naimi J; Elias N; Barkun J
Transplant Proc; 1996 Aug; 28(4):2247-9. PubMed ID: 8769214
[No Abstract] [Full Text] [Related]
2. Transient hyperphosphatasemia after liver transplantation in infancy.
Lachaux A; Chambon M; Boillot O; Le Gall C; Loras I; Canterino I; Pouillaude JM; Gille D; David L; Hermier M
Transplant Proc; 1996 Oct; 28(5):2847. PubMed ID: 8908095
[No Abstract] [Full Text] [Related]
3. Liver transplantation of shipped allografts.
Rafecas A; Ribas Y; Figueras J; Aranda H; Ramos E; Fradera R; Fabregat J; Torras J; Jaurrieta E
Transplant Proc; 1995 Aug; 27(4):2286-7. PubMed ID: 7652808
[No Abstract] [Full Text] [Related]
4. Steroid withdrawal is safe and beneficial in stable cyclosporine-treated liver transplant patients.
Gómez R; Moreno E; Colina F; Loinaz C; Gonzalez-Pinto I; Lumbreras C; Perez-Cerdá F; Castellón C; García I
J Hepatol; 1998 Jan; 28(1):150-6. PubMed ID: 9537852
[TBL] [Abstract][Full Text] [Related]
5. Short- and long-term cyclosporine dosage in liver transplantation.
McCaughan GW; Bookallil MJ; Sheil AG
Transplant Proc; 1994 Oct; 26(5):2674-5. PubMed ID: 7940837
[No Abstract] [Full Text] [Related]
6. Analysis of liver function in renal transplant recipients undergoing C2-monitoring for cyclosporine.
Hecking M; Kainz A; Schillinger M; Posch C; Birsan T; Rasoul-Rockenschaub S; Böhmig GA; Schmaldienst S; Watschinger B; Hörl WH; Mühlbacher F; Säemann MD
Transpl Int; 2008 Mar; 21(3):223-33. PubMed ID: 17903183
[TBL] [Abstract][Full Text] [Related]
7. Intensive care after orthotopic liver transplantation.
Sun CK; Chen CL; Kuo YC; Chen YS
Transplant Proc; 1994 Aug; 26(4):2246-7. PubMed ID: 7520627
[No Abstract] [Full Text] [Related]
8. Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral.
Levy GA
Transplant Proc; 1996 Aug; 28(4):2252-3. PubMed ID: 8769216
[No Abstract] [Full Text] [Related]
9. Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group.
Abouljoud MS; Levy MF; Klintmalm GB
Transplant Proc; 1995 Feb; 27(1):1121-3. PubMed ID: 7533360
[No Abstract] [Full Text] [Related]
10. FK 506 rescue therapy: early conversion improves efficacy.
Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
Transplant Proc; 1993 Apr; 25(2):1990-1. PubMed ID: 7682359
[No Abstract] [Full Text] [Related]
11. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.
Trotter JF; Stolpman N; Wachs M; Bak T; Kugelmas M; Kam I; Everson GT
Liver Transpl; 2002 Mar; 8(3):212-8. PubMed ID: 11910565
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cyclosporine- vs tacrolimus-based immunosuppression in pediatric liver transplantation.
Andrews WS; Sommerauer J; Conlin C; Moore P
Transplant Proc; 1996 Apr; 28(2):897-8. PubMed ID: 8623452
[No Abstract] [Full Text] [Related]
13. Cyclosporine Neoral in renal transplant recipients: impact on hepatic dysfunction.
Bakr MA; Refaie A; Mekresh M; Ihab MH; Sobh M; Ghoneim MA
Transplant Proc; 1997 Nov; 29(7):2939-40. PubMed ID: 9365621
[No Abstract] [Full Text] [Related]
14. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine A reduction and withdrawal in liver transplantation: a risk-benefit analysis.
Golling M; Frankenberg MV; Hofmann WJ; Lohse A; Herfarth C; Otto G
Transplant Proc; 1997 Nov; 29(7):2819-21. PubMed ID: 9365575
[No Abstract] [Full Text] [Related]
16. The significance of local immunosuppression in canine liver transplantation.
Ko S; Nakajima Y; Kanehiro H; Taki J; Aomatsu Y; Yoshimura A; Yagura K; Kin T; Ohashi K; Nakano H
Transplantation; 1994 Jun; 57(12):1818-21. PubMed ID: 8016890
[No Abstract] [Full Text] [Related]
17. Evaluation of clinical safety of conversion to Advagraf therapy in liver transplant recipients: observational study.
Marin-Gomez LM; Gomez-Bravo MA; Alamo-Martinez JA; Barrera-Pulido L; Bernal Bellido C; Suárez Artacho G; Pascasio JM
Transplant Proc; 2009; 41(6):2184-6. PubMed ID: 19715867
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation against positive lymphocytotoxic crossmatches.
Kuo YC; Chen CL; Chen YS; Sun CK
Transplant Proc; 1994 Aug; 26(4):2248-9. PubMed ID: 8066738
[No Abstract] [Full Text] [Related]
19. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.
Charco R; Cantarell C; Vargas V; Capdevila L; Lázaro JL; Hidalgo E; Murio E; Margarit C
Liver Transpl Surg; 1999 May; 5(3):204-8. PubMed ID: 10226111
[TBL] [Abstract][Full Text] [Related]
20. One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults.
Todo S; Fung JJ; Tzakis A; Demetris AJ; Jain A; Alessiani M; Takaya S; Day R; Gordon R; Starzl TE
Transplant Proc; 1991 Feb; 23(1 Pt 2):1397-402. PubMed ID: 1703340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
